Competitive Landscape & Key Players in the Lysosomal Acid Lipase Deficiency Treatment Market, 2025-2030
The global lysosomal acid lipase (LAL) deficiency treatment market was valued at USD 285.3 million in 2024 and is projected to reach USD 433.2 million by 2030, expanding at a CAGR of 7.2% from 2025 to 2030. The market growth is primarily driven by a significant increase in diagnosed cases of LAL-D, a rare genetic disorder that results from a deficiency of the lysosomal acid lipase...
0 Commenti 0 Condivisioni 38 Visualizzazioni